Description
AMPYRA DRUG FOR PATIENTS
First action · last action
2011-03-31 · 2013-03-18
Transactions
2
First transaction's obligation
$89,600
Base + all options value (sum of deltas)
$159,726
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
NO SET ASIDE USED.
Offers received
1
SDVOSB flag on record
No
Parent IDV
V797P6000X
NAICS
424210 · DRUGS AND DRUGGISTS' SUNDRIES MERCHANT WHOLESALERS
Modification chain · 2 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2011-03-31+$89,600= $89,600
- Mod 12013-03-18+$70,126= $159,726
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2011-03-31 | +$89,600 | $89,600 | AMPYRA DRUG FOR PATIENTS |
| Mod 1· FUNDING ONLY ACTION | 2013-03-18 | +$70,126 | $159,726 | AMPYRA DRUG FOR PATIENTS |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI R5D3FUPFFPK4)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C77024N0067 | NATIONAL CMOP OFFICE (36C770) · 6505 · DRUGS AND BIOLOGICALS | $493,607 | FY2024 |
| 36E79724A0005 | NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2024 |
| 36C77024N0027 | NATIONAL CMOP OFFICE (36C770) · 6505 · DRUGS AND BIOLOGICALS | $444,505 | FY2024 |
| 36F79723D0194 | NAC FEDERAL SUPPLY SCHEDULE (36F797) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2023 |
| 36E79723A0011 | NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2023 |
| 36C77023N0057 | NATIONAL CMOP OFFICE (36C770) · 6505 · DRUGS AND BIOLOGICALS | $529,877 | FY2023 |
Other recipients under 6515 from 260-NETWORK CONTRACT OFFICE 20 (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| VA26016F0688 | PEDIGO PRODUCTS, INC. | 260-NETWORK CONTRACT OFFICE 20 | $3,811 | FY2016 |
| VA26016F0656 | THE WINSFORD CORPORATION | 260-NETWORK CONTRACT OFFICE 20 | $58,426 | FY2016 |
| VA26016F0672 | JORDAN RESES SUPPLY COMPANY, LLC | 260-NETWORK CONTRACT OFFICE 20 | $5,376 | FY2016 |
| VA26016F0672 | GOVERNMENT SCIENTIFIC SOURCE INC | 260-NETWORK CONTRACT OFFICE 20 | $7,239 | FY2016 |
| VA26016P0665 | BUFFALO SUPPLY INC. | 260-NETWORK CONTRACT OFFICE 20 | $5,528 | FY2016 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA648C11872_3600_V797P6000X_3600 · retrieved 2026-09-26.